Literature DB >> 20006563

Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis.

Elizabeth F Shead1, Charles S Haworth, Helen Barker, Diana Bilton, Juliet E Compston.   

Abstract

BACKGROUND: Raised levels of pro-inflammatory, pro-resorptive cytokines during pulmonary infection may contribute to osteoporosis in cystic fibrosis (CF). We assessed osteoclast number and activity during infective exacerbations and examined their relationship to serum inflammatory cytokines and bone turnover markers.
METHODS: Serum samples from 24 adults with CF were obtained before, during and after treatment of infection. Osteoclastic cells were generated from peripheral blood mononuclear cells and their number and activity assessed. Serum osteocalcin, type 1 collagen cross-linked N-telopeptide (NTx), interleukin-6 (IL-6), tumour necrosis factor alpha (TNFalpha), receptor activator of NFkB ligand (RANKL) and osteoprotegerin (OPG) were measured.
RESULTS: Osteoclast number and activity were increased at the start of exacerbation and decreased with antibiotic therapy. Significant correlations were demonstrated between osteoclast formation and serum TNFalpha, OPG, osteocalcin and NTx and between osteoclast activity and serum IL-6 and NTx.
CONCLUSIONS: The systemic response to infection is associated with increased bone resorptive activity in patients with CF. Copyright (c) 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006563     DOI: 10.1016/j.jcf.2009.11.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  18 in total

Review 1.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients.

Authors:  D Gensburger; S Boutroy; R Chapurlat; R Nove-Josserand; S Roche; M Rabilloud; I Durieu
Journal:  Osteoporos Int       Date:  2016-05-11       Impact factor: 4.507

Review 3.  Macrophages and skeletal health.

Authors:  Megan N Michalski; Laurie K McCauley
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 4.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

5.  Effects of Exercise Intervention Program on Bone Mineral Accretion in Children and Adolescents with Cystic Fibrosis: A Randomized Controlled Trial.

Authors:  Sumita Gupta; Aparna Mukherjee; Rakesh Lodha; Madhulika Kabra; Kishore K Deepak; Rajesh Khadgawat; Anjana Talwar; Sushil Kumar Kabra
Journal:  Indian J Pediatr       Date:  2019-07-08       Impact factor: 1.967

6.  Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations.

Authors:  A H Gifford; A B Nymon; A Ashare
Journal:  Pediatr Pulmonol       Date:  2013-06-18

Review 7.  Bisphosphonates for osteoporosis in people with cystic fibrosis.

Authors:  Louise S Conwell; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2014-03-14

8.  The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis.

Authors:  David A Ngan; Pearce G Wilcox; May Aldaabil; Yuexin Li; Jonathon A Leipsic; Don D Sin; S F Paul Man
Journal:  BMC Pulm Med       Date:  2012-02-14       Impact factor: 3.317

9.  The role of daily physical activity and nutritional status on bone turnover in cystic fibrosis: a cross-sectional study.

Authors:  Sergio Tejero; Pilar Cejudo; E Quintana-Gallego; Borja Sañudo; A Oliva-Pascual-Vaca
Journal:  Braz J Phys Ther       Date:  2016-03-18       Impact factor: 3.377

10.  Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.

Authors:  Michael S Stalvey; Katrina L Clines; Viktoria Havasi; Christopher R McKibbin; Lauren K Dunn; W Joon Chung; Gregory A Clines
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.